biote Corp. (BTMD): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$39.22M
Year ended 2025-12-31
$18.60M
Trailing 12 months to 2026-06-30
2021-12-31: $35.96M2022-12-31: -$58.52M2023-12-31: $31.65M2024-12-31: $35.19M2025-12-31: $39.22M$39.22M
2021-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$39.22M+11.5%2026-03-13, From 2025-01-01
2024-12-31$35.19M+11.2%2026-03-13, From 2024-01-01
2023-12-31$31.65Mn/m2025-03-14, From 2023-01-01
2022-12-31-$58.52Mn/m2024-03-15, From 2022-01-01
2021-12-31$35.96Mn/a2023-03-29, From 2021-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
biote Corp. (BTMD)2025-12-31$39.22M+11.5%
Glass House Brands Inc. (GLAS)2025-12-31-$1.53Mn/m
Marimed Inc. (MRMD)2025-12-31$5.29M-49.7%
Cronos Group Inc. (CRON)2025-12-31-$3.16Mn/m
Jushi Holdings Inc. (JUSH)2025-12-31$35.84M-12.1%
Natural Alternatives International Inc (NAII)2025-06-30-$4.10Mn/m
Mannatech Inc (MTEX)2025-12-31$666.0K-77.5%
Fitlife Brands, Inc. (FTLF)2025-12-31$10.48M-20.8%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$56.52M-20.3%

Compare BTMD, GLAS, MRMD, CRON side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗